Free Trial
NASDAQ:RGC

Regencell Bioscience (RGC) Stock Price, News & Analysis

Regencell Bioscience logo
$15.10 -0.04 (-0.26%)
As of 09/26/2025 04:00 PM Eastern

About Regencell Bioscience Stock (NASDAQ:RGC)

Advanced

Key Stats

Today's Range
$14.94
$15.36
50-Day Range
$12.28
$15.64
52-Week Range
$0.09
$83.60
Volume
62,691 shs
Average Volume
227,227 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Regencell Bioscience Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
10th Percentile Overall Score

RGC MarketRank™: 

Regencell Bioscience scored higher than 10% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Regencell Bioscience.

  • Price to Book Value per Share Ratio

    Regencell Bioscience has a P/B Ratio of 755.00. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    9.99% of the float of Regencell Bioscience has been sold short.
  • Short Interest Ratio / Days to Cover

    Regencell Bioscience has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Regencell Bioscience has recently decreased by 15.93%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Regencell Bioscience does not currently pay a dividend.

  • Dividend Growth

    Regencell Bioscience does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    9.99% of the float of Regencell Bioscience has been sold short.
  • Short Interest Ratio / Days to Cover

    Regencell Bioscience has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Regencell Bioscience has recently decreased by 15.93%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Regencell Bioscience has a news sentiment score of 1.53. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.31 average news sentiment score of Manufacturing companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Regencell Bioscience this week, compared to 2 articles on an average week.
  • Search Interest

    20 people have searched for RGC on MarketBeat in the last 30 days. This is an increase of 186% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Regencell Bioscience to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Regencell Bioscience insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 2.00% of the stock of Regencell Bioscience is held by insiders.

  • Percentage Held by Institutions

    Only 0.13% of the stock of Regencell Bioscience is held by institutions.

  • Read more about Regencell Bioscience's insider trading history.
Receive RGC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Regencell Bioscience and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

RGC Stock News Headlines

Regencell Bioscience Holdings (RGC) Climbs 11% Over Last Week
Regencell Bioscience: Down 80%, More Downside Is Likely
Why More Investors Are Using Family Trusts to Protect Their Wealth
For many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensuring wealth is passed on according to your wishes. Trusts may also provide shielding from creditors and lawsuits while offering potential tax advantages—especially with estate tax thresholds set to decrease in 2026. If you’re considering whether a family trust is right for you, speaking with a fiduciary financial advisor can help you decide the best path forward. We’ve created a free tool that matches you with vetted advisors in your area—each legally bound to act in your best interest.tc pixel
RGC Resources: The Impact Of MVP
See More Headlines

RGC Stock Analysis - Frequently Asked Questions

Regencell Bioscience's stock was trading at $63.35 at the start of the year. Since then, RGC shares have decreased by 76.2% and is now trading at $15.10.

Regencell Bioscience shares split before market open on Monday, June 16th 2025.The 38-1 split was announced on Monday, June 2nd 2025. The newly minted shares were distributed to shareholders after the closing bell on Sunday, June 15th 2025. An investor that had 100 shares of stock prior to the split would have 3,800 shares after the split.

Regencell Bioscience (RGC) raised $22 million in an initial public offering on Friday, July 16th 2021. The company issued 2,300,000 shares at a price of $8.50-$10.50 per share.

Top institutional shareholders of Regencell Bioscience include Geode Capital Management LLC, Squarepoint Ops LLC, Squarepoint Ops LLC and BNP Paribas Financial Markets.

Shares of RGC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
9/27/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Medicinal Chemicals
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:RGC
Previous Symbol
NASDAQ:RGC
CIK
1829667
Web
N/A
Employees
10
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.02 per share
Price / Book
755.00

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
N/A
Beta
2.16
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NASDAQ:RGC) was last updated on 9/27/2025 by MarketBeat.com Staff
From Our Partners